SCHEMBL22685305

SCHEMBL22685305

C#Cc1ccc(C(=O)NC2(c3ncc(-c4cccnc4C)cn3)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ CYP2C8 P10632 4/20 0.40
▸ KCNH2 Q12809 3/20 0.40
▸ CYP3A4 P08684 3/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSB P07858 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ CXCR3 P49682 1/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.33
▸ P2RY14 Q15391 1/20 0.33
▸ ROCK2 O75116 2/20 0.33
▸ EGLN1 Q9GZT9 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33
▸ NR1I2 O75469 1/20 0.32
▸ NAMPT P43490 1/20 0.32
▸ IDO1 P14902 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22685306 0.79 IDO1 (0.41) CTSLCTSBCTSSCXCR3AKT1
SCHEMBL22685085 0.72 AKT1 (0.38) ABL1CTSLCTSBCTSSCXCR3
SCHEMBL22685302 0.71 CTSL (0.37) CTSLCTSBCTSSCXCR3ROCK2
SCHEMBL22686792 0.71 PDE2A (0.43) ABL1CXCR3AKT1
SCHEMBL22685301 0.69 CTSL (0.40) CYP2C8KCNH2CYP3A4CTSLCTSB
SCHEMBL22685090 0.69 CD274 (0.43) CTSLCTSBCTSSAKT1HDAC6
SCHEMBL22657417 0.68 MKNK1 (0.45) MKNK1MKNK2ABL1CTSLCTSB
SCHEMBL22684819 0.68 PTPN1 (0.42) CYP2C8KCNH2CYP3A4CTSLCTSB
SCHEMBL22657413 0.68 DEGS1 (0.42) ABL1CTSLCTSBCTSS
SCHEMBL22686795 0.68 BTK (0.38) ABL1CTSLCTSBCTSSAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020228823-A1 NOVEL AMIDE COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2020-11-19 — — WO disclosed
Send feedback